←back to thread

Cost of developing new drugs may be lower than industry claims: trial

(www.theguardian.com)
275 points swores | 1 comments | 25 Apr 24 12:25 UTC | HN request time: 0s | source
Show context
hi-v-rocknroll ◴[26 Apr 24 19:23 UTC] No.40173019[source]▶
Semaglutide retails for $17k USD/year in the US but costs only $60 to make. Perhaps it could be argued that the autoinjectors are "expensive", but not $17k/year and oral forms are coming online to make this item moot. In limited circumstances, excessive profits cross into the realm of price gouging and shouldn't be allowed by regulatory enforcement.
replies(9): >>40173117 #>>40173204 #>>40173218 #>>40173309 #>>40173371 #>>40173374 #>>40173583 #>>40173707 #>>40174265 #
0cf8612b2e1e ◴[26 Apr 24 19:48 UTC] No.40173374[source]▶
The first pill of a drug costs $1 billion to make. The remainder are all $0.01 a piece.
replies(3): >>40173557 #>>40173920 #>>40174219 #
1. geysersam ◴[26 Apr 24 20:32 UTC] No.40173920[source]▶
In that sense it's not so different from digital content. Another arena where IP concept from the last century are a bad fit